Gibson, Dunn & Crutcher LLP and Walkers (Cayman) LLP have advised MoonLake Immunotherapeutics. Mintz has advised the underwriters. MoonLake Immunotherapeutics (NASDAQ: MLTX) has completed a public...
MoonLake Immunotherapeutics Completes $200 Million Public Offering of Class A Shares
Rallybio to Acquire Avenzo Therapeutics and Complete $215 Million Private Placement
Cooley has advised Avenzo Therapeutics. Ropes & Gray has advised Rallybio Corporation. Mintz has advised the placement agents. Rallybio Corporation has entered into a definitive agreement...
NervGen Pharma Completes $60 Million Public Offering
Joseph Garcia from Blake, Cassels & Graydon LLP has advised NervGen Pharma. Mintz has advised the underwriters. NervGen Pharma has completed a public offering valued at...
Obsidian Therapeutics and Galera Therapeutics Announce $350 Million Merger and Private Placement
Goodwin Procter LLP has advised Obsidian Therapeutics. Sidley Austin LLP has advised Galera Therapeutics. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. has advised the placement...
ImageneBio Completes $30 Million Private Placement to Advance Clinical Programs
Cooley LLP has advised ImageneBio, Inc. on the deal, and Mintz has advised Leerink Partners as sole placement agent. ImageneBio, Inc. (Nasdaq: IMA) has announced the...
Eupraxia Pharmaceuticals Closes US$63.2 Million Public Offering
Mintz and Stikeman Elliott LLP have advised the underwriters. Troutman Pepper and Blake, Cassels & Graydon LLP have advised Eupraxia Pharmaceuticals. Eupraxia Pharmaceuticals Inc., a clinical-stage...
Fulcrum Therapeutics Prices $175 Million Public Offering of Stock and Pre-Funded Warrants
Goodwin Procter LLP has advised Fulcrum Therapeutics. Mintz has advised the underwriters. Fulcrum Therapeutics, Inc. (“Fulcrum”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company, has announced the pricing...
Cogent Biosciences Announces $230 Million Convertible Senior Notes Offering
Gibson Dunn has represented Cogent Biosciences, Inc., and Mintz has advised the underwriters. Cogent Biosciences, Inc. (Nasdaq: COGT) has announced the pricing of its underwritten public...
Cogent Biosciences Completes $345 Million Common Stock Offering and $200 Million Convertible Notes Offering
Gibson Dunn has represented Cogent Biosciences, Inc., Mintz has advised the underwriters. Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for...
MoonLake Immunotherapeutics Completes $75 Million Follow-on Equity Offering
Gibson, Dunn & Crutcher LLP and Walkers (Cayman) LLP have advised MoonLake Immunotherapeutics. Mintz has advised Leerink Partners. MoonLake Immunotherapeutics has completed the pricing of an...
Praxis Precision Medicines Completes $603 Million Public Offering
Latham & Watkins has advised Praxis Precision Medicines, Inc., and Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo has advised the underwriters. Praxis Precision Medicines, Inc. (Nasdaq:...
Ondas Holdings Completes $230 Million Underwritten Offering of Common Stock
Akerman LLP has advised Ondas Holdings Inc. on the offering, and Mintz has advised the underwriters. Ondas Holdings Inc., a leading provider of autonomous aerial and...